Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treat

Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests (Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test)), By End User (Diagnostic Laboratories, Private Laboratories, Public Laboratories, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Rheumatoid Arthritis is an autoimmune disease which leads joint pain due to inflammation of joint lining. The condition usually affects the hands, feet and wrists. Blood tests commonly used to diagnose RA include, rheumatoid factor anti-cyclic citrullinated peptide, C - reactive protein (CRP), and Erythrocyte Sedimentation Rate (ESR). Increasing prevalence of RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period. Furthermore, development of new blood tests for RA is also expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period
Key features of the study:
This report provides in-depth analysis of the Rheumatoid Arthritis Diagnostic Tests market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Rheumatoid Arthritis Diagnostic Tests market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Rheumatoid Arthritis Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market
Detailed Segmentation:
Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
Rheumatoid Arthritis Diagnostic Tests Market, By End User:
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
Rheumatoid Arthritis Diagnostic Tests Market, By Region:
North America
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Test Type:
Serology Test
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
By End User
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Abbott Diagnostics (Abbott Laboratories) *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Antibodies Inc.
Beckman Coulter, Inc.
Euro Diagnostica AB
F. Hoffmann-La Roche Ltd.
Qiagen NV
Siemens Healthcare Gmb
Thermo Fisher Scientific Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Test Type
Market Snippets, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions
4. Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Serology Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Salicylate Level Count
Muscle Enzyme Tests (CPK, Aldolase)
Creatinine Test
5. Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospital
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Private Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Public Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Rheumatoid Arthritis Diagnostic Tests Market, By Region, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2022 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
South Africa
Central Africa
North Africa
7. Competitive Landscape
Company Profiles
Abbott Diagnostics (Abbott Laboratories)
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Antibodies Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Beckman Coulter, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Euro Diagnostica AB
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
F. Hoffmann-La Roche Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Qiagen NV
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Siemens Healthcare GmbH
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Thermo Fisher Scientific Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 18 figures on “Rheumatoid Arthritis Diagnostic Tests Market - Global forecast to 2028”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings